Microglia constitute the central therapeutic priority for X-ALD due to its high ABCD1 expression and pivotal role in neuronal homeostasis and inflammatory regulation, making them particularly vulnerable to the toxic effects of accumulating VLCFA as they actively express ABCD1 in human and mouse brain [60]. The gene discussed is ABCD1; the disease is adrenoleukodystrophy.